Michael J. Purcell, Director at Hepion Pharmaceuticals, Inc. (HEPA), bought 2,000,000 shares at $0.05 ($100K) on 2026-08-03, disclosed to the SEC on 2026-08-12.
Director Michael J. Purcell executed a massive $100,000 purchase of 2,000,000 shares at $0.05, marking the largest insider trade in the company's history and signaling strong conviction in the stock's current valuation.
HEPA is currently trading at $0.3181, sitting exactly at its 52-week high with a 0.0% change over the last 5, 30, and 90 days, indicating a consolidation phase near its peak.
Insider cluster momentum: 2 other insiders purchased shares in the last 30 days, creating a buying cluster that warrants attention.
Short interest risk: The stock carries a short interest of approximately 4.1% of the float, which could lead to volatility if the stock moves higher.
Something here stands out, but not much.
| Filing → |
| TRHC | BUY | 2022-03-03 | $58K | — | Filing → |
| IMXI | BUY | 2021-11-22 | $105K | — | Filing → |
| TRHC | BUY | 2021-11-12 | $273K | — | Filing → |